Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections.

about

Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections.

Item

http://www.wikidata.org/entity/Q41989976

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Clinical and pharmacokinetic d ...... and skin structure infections.

@en

type

Item

label

Clinical and pharmacokinetic d ...... and skin structure infections.

@en

prefLabel

Clinical and pharmacokinetic d ...... and skin structure infections.

@en

P1476

Clinical and pharmacokinetic d ...... and skin structure infections

@en

P2093

Davide Pecori

http://www.w3.org/2001/XMLSchema#string

Federico Pea

http://www.w3.org/2001/XMLSchema#string

Matteo Bassetti

http://www.w3.org/2001/XMLSchema#string

Piergiorgio Cojutti

http://www.w3.org/2001/XMLSchema#string

P2860

Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy

Trends in US hospital admissions for skin and soft tissue infections

Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.

Delafloxacin for the treatment of respiratory and skin infections.

A thorough QT study to evaluate the effects of therapeutic and supratherapeutic doses of delafloxacin on cardiac repolarization.

In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone.

A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin

A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms.

In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.

Why is community-associated MRSA spreading across the world and how will it change clinical practice?

P304

1193-1200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17425255.2017.1386654

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elda Righi

P577

2017-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28988505

http://www.w3.org/2001/XMLSchema#string